| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice President & CFO | Director
2 companies
David Patrick Williams last filed a Form 4 in November 2023, as Director at RGS. The filings on record cover 2 companies. From February 2015 to November 2023, the filings on record show 4 open-market purchases and 18 sales. David Patrick Williams's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, David Patrick Williams's trades have earned a middling insider score of 56/100 across 9 rated trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of -4.2%.
At the last filing, the largest reported position was 5,826 shares of CHE. The CHE filings lean toward selling, a net 148,692 shares.
Shares as reported in the last Form 4 for each company; the most recent is from November 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2018 | CHE Chemed Corp | Executive Vice President & CFO | Sell | 10,000 | $302.30 | $3,023,000.00 | -28.6% | |
| May 11, 2018 | CHE Chemed Corp | Executive Vice President & CFO | Sell | 10,000 | $326.17 | $3,261,700.00 | -22.0% | |
| May 7, 2018 | CHE Chemed Corp | Executive Vice President & CFO | Sale+OE | 10,000 | $316.08 | $3,160,800.00 | -21.1% | |
| Apr 25, 2018 | CHE Chemed Corp | Executive Vice President & CFO | Sale+OE | 15,713 | $301.86 | $4,743,167.34 | -26.8% | |
| Feb 8, 2018 | RGS Regis Corp | Director | Buy | 5,000 | $15.50 | $77,500.00 | +5.4% | |
| Nov 29, 2017 | CHE Chemed Corp | Executive Vice President & CFO | Sale+OE | 11,000 | $241.28 | $2,654,050.00 | -20.5% | |
| May 8, 2017 | RGS Regis Corp | Director | Buy | 10,000 | $9.61 | $96,125.00 | +14.2% | |
| Dec 11, 2015 | CHE Chemed Corp | Executive Vice President & CFO | Sell | 5,000 | $151.72 | $758,575.00 | -11.9% | |
| Sep 3, 2015 | RGS Regis Corp | Director | Buy | 10,000 | $11.28 | $112,800.00 | +25.7% | |
| Aug 24, 2015 | CHE Chemed Corp | Executive Vice President & CFO | Sell | 10,000 | $138.09 | $1,380,900.00 | -25.5% |